SM

Sharad Mehrotra

Active Director Director DIN 05318392
DIN 05318392 First appointment Aug 2012 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2012
Shareholding value •••• Premium profile

About Sharad Mehrotra

Data last updated:

Sharad Mehrotra is a Director at Mutual Pharma Private Limited (since 2012). The company operates in Healthcare. Mutual Pharma Private Limited reported revenue of ₹1.96 Cr (FY 2017).

DIN 05318392
Primary Designation Director
Industry Healthcare
First Appointment 27 Aug 2012
Oldest Company Age 14 yrs
Largest company Mutual Pharma Private Limited · ₹1.96 Cr (FY 2017)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mutual Pharma Private Limited U51909HR2012PTC046908
Director27 Aug 20122012₹1.96 Cr (FY 2017)Active

Board colleagues of Sharad Mehrotra

NameDINCompanyDesignation
Manish Mehrotra06689300Mutual Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mutual Pharma Private Limited
Premium access

Shareholding and investment profile for Sharad Mehrotra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sharad Mehrotra

Sharad Mehrotra currently holds 1 directorship: Mutual Pharma Private Limited (Director, since 27 Aug 2012, revenue ₹1.96 Cr (FY 2017)).

Sharad Mehrotra was first appointed on 27 Aug 2012 as Director at Mutual Pharma Private Limited.

The current boards of Sharad Mehrotra's companies include Manish Mehrotra (Mutual Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available